Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cells generated directly from mature cells through the introduction of key transcription factors. iPSCs can be propagated and differentiated into many cell types in the human body, holding enormous potential in the field of regenerative medicine. However, genomic instability of iPSCs has been reported with the advent of high-throughput technologies such as next-generation sequencing. The presence of genetic variations in iPSCs has raised serious safety concerns, hampering the advancement of iPSC-based novel therapies. Here we summarize our current knowledge on genomic instability of iPSCs, with a particular focus on types of genetic variations and their origins. Importantly, it remains elusive whether genetic variations in iPSCs can be an actual risk factor for adverse effects including malignant outgrowth. Furthermore, we discuss novel approaches to generate iPSCs with fewer genetic variations. Lastly, we outline the safety issues and monitoring strategies of iPSCs in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, these iPSC models encounter significant reproducibility challenges. When in a pluripotent state, they are highly sensitive to external environmental cues, modifying internal genomic architecture, becoming unsuitable for differentiations11.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Following previous studies in the literature, it is known that iPSC genomic architecture can change over time whilst these cells are in culture11 and this can have a noticeable impact on differentiation protocols21.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [11]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, variability in differentiation outcomes presents a major barrier to reproducibility and model reliability.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 2×
“Since the establishment of human iPSCs in 2007 [2, 3], many attempts have been made to produce iPSCs more efficiently and safely.”
BackgroundThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066 · cited 1×
“netic variations across the entire genome at single nucleotide resolution [17] and (ii) low frequency variations which could not be identified by conventional methods [18], revolutionizing the field of genomic research including genomic studies of iPSCs.”
BackgroundAge-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“Somatic mutations, including cancer driver mutations, have been shown to accumulate in blood cells with increasing age [70, 71].”
BackgroundThe pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 1×
“[47] for review) Tumorigenic potential might also differ depending on the environment [48] surrounding the transplanted cells.”
BackgroundComing of age: ten years of next-generation sequencing technologies
Goodwin, S., McPherson, J. D., & McCombie, W. R. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.49 · Cited by 4,352
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531 · cited 1×
“Somatic mutations, including cancer driver mutations, have been shown to accumulate in blood cells with increasing age [70, 71].”
BackgroundComparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · cited 1×
“In addition, several DNA-free reprogramming methods such as protein-based methods [90, 91] or mRNA-based methods [92] have also been developed.”
MethodHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Forbes, S. A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1075 · Cited by 2,283
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“to many diseases involving other organs such as liver [116], kidney [117], and cornea [118] (for review see Okano &”
BackgroundWang, D. G., Fan, J.-B., Siao, C.-J., Berno, A., Young, P., Sapolsky, R., Ghandour, G., Perkins, N., Winchester, E., Spencer, J., et al. (1998) · Science · doi:10.1126/science.280.5366.1077 · Cited by 2,161
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423 · cited 1×
“In addition, iPSCs can also be generated from cells isolated from urine [65], hair keratinocyte [66], mesenchymal stromal cells derived from wisdom teeth [67].”
BackgroundFUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411 · cited 1×
“To circumvent this problem, integration-free vectors such as expression plasmids [86], Sendai virus vectors [87], and episomal plasmid vectors [88, 89] have been developed.”
MethodPluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., et al. (2013) · Science · doi:10.1126/science.1239278 · Cited by 1,402
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
Optical Coherence Tomography: An Emerging Technology for Biomedical Imaging and Optical Biopsy
Fujimoto, J. G., Pitris, C., Boppart, S. A., & Brezinski, M. E. (2000) · Neoplasia · doi:10.1038/sj.neo.7900071 · Cited by 1,138
Advances in understanding cancer genomes through second-generation sequencing
Meyerson, M., Gabriel, S., & Getz, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2841 · Cited by 1,116
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., de Lima, M., Finke, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041469 · Cited by 1,101
Chin, M. H., Mason, M. J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.06.008 · Cited by 1,035
Copy number variation and selection during reprogramming to pluripotency
Hussein, S. M., Batada, N. N., Vuoristo, S., Ching, R. W., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. (2011) · Nature · doi:10.1038/nature09871 · Cited by 954
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890 · cited 16×
“These technologies allow us to investigate copy number variations (CNVs) (i.e., duplications and deletions) across the whole genome at kilobase resolution (for review see Le Scouarnec & Gribble [15]).”
BackgroundInfluentialTaguchi, A., Kaku, Y., Ohmori, T., Sharmin, S., Ogawa, M., Sasaki, H., & Nishinakamura, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.010 · Cited by 865
High Resolution of Human Chromosomes
Yunis, J. J. (1976) · Science · doi:10.1126/science.1257746 · Cited by 783
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells
Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A. T., Plath, K., Lowry, W. E., & Benvenisty, N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.017 · Cited by 756
Okita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A., Goshima, N., & Yamanaka, S. (2013) · Stem Cells · doi:10.1002/stem.1293 · Cited by 749
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. (2014) · Nature · doi:10.1038/nature13305 · Cited by 656
Generation of induced pluripotent stem cells from human blood
Loh, Y.-H., Agarwal, S., Park, I.-H., Urbach, A., Huo, H., Heffner, G. C., Kim, K., Miller, J. D., Ng, K., & Daley, G. Q. (2009) · Blood · doi:10.1182/blood-2009-02-204800 · Cited by 626
Pluripotent stem cells in disease modelling and drug discovery
Avior, Y., Sagi, I., & Benvenisty, N. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.27 · Cited by 592
KLF4, p21 and context-dependent opposing forces in cancer
Rowland, B. D., & Peeper, D. S. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1780 · Cited by 551
Deterministic direct reprogramming of somatic cells to pluripotency
Rais, Y., Zviran, A., Geula, S., Gafni, O., Chomsky, E., Viukov, S., Mansour, A. A., Caspi, I., Krupalnik, V., Zerbib, M., et al. (2013) · Nature · doi:10.1038/nature12587 · Cited by 522 · cited 2×
“Recently, NuRD (nucleosome remodeling and deacetylation) component Mbd3 has been identified as a major reprogramming barrier during iPSC induction [93].”
BackgroundAraki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., Sugiura, M., Ideno, H., Shimada, A., Nifuji, A., et al. (2013) · Nature · doi:10.1038/nature11807 · Cited by 505
Optical coherence tomography to detect and manage retinal disease and glaucoma
Jaffe, G. J., & Caprioli, J. (2004) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00792-x · Cited by 505
A continuum model for tumour suppression
Berger, A. H., Knudson, A. G., & Pandolfi, P. P. (2011) · Nature · doi:10.1038/nature10275 · Cited by 501
Emerging patterns of somatic mutations in cancer
Watson, I. R., Takahashi, K., Futreal, P. A., & Chin, L. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3539 · Cited by 491
Genome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484
Generation of Induced Pluripotent Stem Cells from Human Cord Blood
Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., Zweigerdt, R., Gruh, I., Meyer, J., Wagner, S., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.08.021 · Cited by 481
Adult frogs derived from the nuclei of single somatic cells
Gurdon, J. B. (1962) · Developmental Biology · doi:10.1016/0012-1606(62)90043-x · Cited by 462
Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells
Staerk, J., Dawlaty, M. M., Gao, Q., Maetzel, D., Hanna, J., Sommer, C. A., Mostoslavsky, G., & Jaenisch, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.002 · Cited by 459
Oct-3/4 is a dose-dependent oncogenic fate determinant
Gidekel, S., Pizov, G., Bergman, Y., & Pikarsky, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00270-8 · Cited by 441
Taylor, C. J., Peacock, S., Chaudhry, A. N., Bradley, J. A., & Bolton, E. M. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.07.014 · Cited by 428
Generation of Induced Pluripotent Stem Cells from Human Cord Blood Using OCT4 and SOX2
Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodríguez-Pizà, I., Vassena, R., Raya, A., Boué, S., Barrero, M. J., Corbella, B. A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.008 · Cited by 408
Ye, Z., Zhan, H., Mali, P., Dowey, S., Williams, D. M., Jang, Y.-Y., Dang, C. V., Spivak, J. L., Moliterno, A. R., & Cheng, L. (2009) · Blood · doi:10.1182/blood-2009-04-217406 · Cited by 399
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells
Abyzov, A., Mariani, J., Palejev, D., Zhang, Y., Haney, M. S., Tomasini, L., Ferrandino, A. F., Rosenberg Belmaker, L. A., Szekely, A., Wilson, M., et al. (2012) · Nature · doi:10.1038/nature11629 · Cited by 384
A role for Lin28 in primordial germ-cell development and germ-cell malignancy
West, J. A., Viswanathan, S. R., Yabuuchi, A., Cunniff, K., Takeuchi, A., Park, I.-H., Sero, J. E., Zhu, H., Perez-Atayde, A., Frazier, A. L., et al. (2009) · Nature · doi:10.1038/nature08210 · Cited by 375
Tang, C., Lee, A. S., Volkmer, J.-P., Sahoo, D., Nag, D., Mosley, A. R., Inlay, M. A., Ardehali, R., Chavez, S. L., Pera, R. R., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1947 · Cited by 375
Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application
Liang, G., & Zhang, Y. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.07.001 · Cited by 369
Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P., & Boyd, A. S. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.01.006 · Cited by 368 · cited 2×
“Although immune rejection can be avoided in autologous transplantation of patient-matched iPSCs [6, 7], generation of patientderived iPSCs is a time-consuming and expensive processes [79].”
BackgroundDNA damage and ageing: new-age ideas for an age-old problem
Garinis, G. A., van der Horst, G. T. J., Vijg, J., & H.J. Hoeijmakers, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1108-1241 · Cited by 366 · cited 1×
“Given that aging is associated with increased DNA damage [68], iPSCs derived from elderly patients might possess larger number of mutations.”
BackgroundScotto, L., Narayan, G., Nandula, S. V., Arias‐Pulido, H., Subramaniyam, S., Schneider, A., Kaufmann, A. M., Wright, J. D., Pothuri, B., Mansukhani, M., et al. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20577 · Cited by 333
Abnormalities in human pluripotent cells due to reprogramming mechanisms
Ma, H., Morey, R., O'Neil, R. C., He, Y., Daughtry, B., Schultz, M. D., Hariharan, M., Nery, J. R., Castanon, R., Sabatini, K., et al. (2014) · Nature · doi:10.1038/nature13551 · Cited by 332
Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells
Taapken, S. M., Nisler, B. S., Newton, M. A., Sampsell-Barron, T. L., Leonhard, K. A., McIntire, E. M., & Montgomery, K. D. (2011) · Nature Biotechnology · doi:10.1038/nbt.1835 · Cited by 327
Fredriksson, N. J., Ny, L., Nilsson, J. A., & Larsson, E. (2014) · Nature Genetics · doi:10.1038/ng.3141 · Cited by 289
The pluripotency homeobox gene NANOG is expressed in human germ cell tumors
Hart, A. H., Hartley, L., Parker, K., Ibrahim, M., Looijenga, L. H. J., Pauchnik, M., Chow, C. W., & Robb, L. (2005) · Cancer · doi:10.1002/cncr.21435 · Cited by 263
Co-ordinated ocular development from human iPS cells and recovery of corneal function
Hayashi, R., Ishikawa, Y., Sasamoto, Y., Katori, R., Nomura, N., Ichikawa, T., Araki, S., Soma, T., Kawasaki, S., Sekiguchi, K., et al. (2016) · Nature · doi:10.1038/nature17000 · Cited by 258
Genetic and epigenetic stability of human pluripotent stem cells
Lund, R. J., Närvä, E., & Lahesmaa, R. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3271 · Cited by 250
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules
Lee, M.-O., Moon, S. H., Jeong, H.-C., Yi, J.-Y., Lee, T.-H., Shim, S. H., Rhee, Y.-H., Lee, S.-H., Oh, S.-J., Lee, M.-Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303669110 · Cited by 246 · cited 2×
“In addition to genomic instability, contamination of residual undifferentiated iPSCs or residual exogenous genes could play a role in tumorigenesis after transplantation [114].”
BackgroundCheng, L., Hansen, N. F., Zhao, L., Du, Y., Zou, C., Donovan, F. X., Chou, B.-K., Zhou, G., Li, S., Dowey, S. N., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.01.005 · Cited by 238
Recurrent somatic mutations in regulatory regions of human cancer genomes
Melton, C., Reuter, J. A., Spacek, D. V., & Snyder, M. (2015) · Nature Genetics · doi:10.1038/ng.3332 · Cited by 236
iPS cell technologies: significance and applications to CNS regeneration and disease
Okano, H., & Yamanaka, S. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-22 · Cited by 233
Almstrup, K., Hoei-Hansen, C. E., Wirkner, U., Blake, J., Schwager, C., Ansorge, W., Nielsen, J. E., Skakkebæk, N. E., Meyts, E. R.-D., & Leffers, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0679 · Cited by 233
Chance or necessity? Insertional Mutagenesis in Gene Therapy and Its Consequences
Baum, C., von Kalle, C., Staal, F. J. T., Li, Z., Fehse, B., Schmidt, M., Weerkamp, F., Karlsson, S., Wagemaker, G., & Williams, D. A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.10.013 · Cited by 225
Nori, S., Okada, Y., Nishimura, S., Sasaki, T., Itakura, G., Kobayashi, Y., Renault-Mihara, F., Shimizu, A., Koya, I., Yoshida, R., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.006 · Cited by 220
Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs
Kang, E., Wang, X., Tippner-Hedges, R., Ma, H., Folmes, C. D. L., Gutierrez, N. M., Lee, Y., Van Dyken, C., Ahmed, R., Li, Y., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.005 · Cited by 215
RIKEN suspends first clinical trial involving induced pluripotent stem cells
Garber, K. (2015) · Nature Biotechnology · doi:10.1038/nbt0915-890 · Cited by 215 · cited 3×
“of iPSC-derived RPE cell transplantation, ocular fundus can be observed noninvasively [10], and morphological changes of transplanted RPE can be monitored at cellular levels using optical coherence tomography [112, 113].”
BackgroundMethodRecurrent copy number variations in human induced pluripotent stem cells
Martins-Taylor, K., Nisler, B. S., Taapken, S. M., Compton, T., Crandall, L., Montgomery, K. D., Lalande, M., & Xu, R.-H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1890 · Cited by 213 · cited 2×
“21 as the most recurrent CNV hotspot [21, 22, 27].”
BackgroundYoung, M. A., Larson, D. E., Sun, C.-W., George, D. R., Ding, L., Miller, C. A., Lin, L., Pawlik, K. M., Chen, K., Fan, X., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.002 · Cited by 197
Ji, J., Ng, S. H., Sharma, V., Neculai, D., Hussein, S., Sam, M., Trinh, Q., Church, G. M., Mcpherson, J. D., Nagy, A., et al. (2012) · STEM CELLS · doi:10.1002/stem.1011 · Cited by 193
Origins and molecular biology of testicular germ cell tumors
Reuter, V. E. (2005) · Modern Pathology · doi:10.1016/s0893-3952(22)04458-1 · Cited by 186
Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells
Xue, Y., Cai, X., Wang, L., Liao, B., Zhang, H., Shan, Y., Chen, Q., Zhou, T., Li, X., Hou, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070573 · Cited by 183
Computational approaches to identify functional genetic variants in cancer genomes
the International Cancer Genome Consortium Mutation Pathways and Consequences Subgroup of the Bioinformatics Analyses Working Group (2013) · Nature Methods · doi:10.1038/nmeth.2562 · Cited by 171
Human Somatic Cell Nuclear Transfer Using Adult Cells
Chung, Y. G., Eum, J. H., Lee, J. E., Shim, S. H., Sepilian, V., Hong, S. W., Lee, Y., Treff, N. R., Choi, Y. H., Kimbrel, E. A., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.03.015 · Cited by 171
Nakajima, F., Tokunaga, K., & Nakatsuji, N. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0566 · Cited by 168 · cited 1×
“Importantly, a small number of homozygous human leukocyte antigen (HLA) types could cover a large portion of populations [80, 81], making them ideal biological resources for allogeneic transplantation [79].”
BackgroundJiang, J., Lv, W., Ye, X., Wang, L., Zhang, M., Yang, H., Okuka, M., Zhou, C., Zhang, X., Liu, L., et al. (2012) · Cell Research · doi:10.1038/cr.2012.157 · Cited by 156
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy
Howden, S. E., Gore, A., Li, Z., Fung, H.-L., Nisler, B. S., Nie, J., Chen, G., McIntosh, B. E., Gulbranson, D. R., Diol, N. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103388108 · Cited by 148
Induction of Pluripotent Stem Cells from Human Third Molar Mesenchymal Stromal Cells*
Oda, Y., Yoshimura, Y., Ohnishi, H., Tadokoro, M., Katsube, Y., Sasao, M., Kubo, Y., Hattori, K., Saito, S., Horimoto, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.055889 · Cited by 137
Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases
Murakawa, Y., Yoshihara, M., Kawaji, H., Nishikawa, M., Zayed, H., Suzuki, H., & Hayashizaki, Y. (2016) · Trends in Genetics · doi:10.1016/j.tig.2015.11.004 · Cited by 134
Self-citationWhole-genome mutational burden analysis of three pluripotency induction methods
Bhutani, K., Nazor, K. L., Williams, R., Tran, H., Dai, H., Džakula, Ž., Cho, E. H., Pang, A. W. C., Rao, M., Cao, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10536 · Cited by 129 · cited 3×
“mutations distributed throughout the genome [58].”
BackgroundInfluentialJóhannesson, B., Sagi, I., Gore, A., Paull, D. J., Yamada, M., Golan‐Lev, T., Li, Z., LeDuc, C. A., Shen, Y., Stern, S., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.10.002 · Cited by 125
Characterising chromosome rearrangements: recent technical advances in molecular cytogenetics
Scouarnec, S. L., & Gribble, S. M. (2011) · Heredity · doi:10.1038/hdy.2011.100 · Cited by 122
Protocols for cytogenetic studies of human embryonic stem cells
Meisner, L. F., & Johnson, J. L. (2008) · Methods · doi:10.1016/j.ymeth.2008.03.005 · Cited by 119
Quinlan, A. R., Boland, M. J., Leibowitz, M. L., Shumilina, S., Pehrson, S. M., Baldwin, K. K., & Hall, I. M. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.07.018 · Cited by 115
Ruiz, S., Lopez-Contreras, A. J., Gabut, M., Marion, R. M., Gutierrez-Martinez, P., Bua, S., Ramirez, O., Olalde, I., Rodrigo-Perez, S., Li, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9036 · Cited by 112
Su, R. J., Baylink, D. J., Neises, A., Kiroyan, J. B., Meng, X., Payne, K. J., Tschudy-Seney, B., Duan, Y., Appleby, N. C., Kearns‐Jonker, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064496 · Cited by 104
Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells
Merling, R. K., Sweeney, C. L., Choi, U., De Ravin, S. S., Myers, T. G., Otaizo-Carrasquero, F., Pan, J., Linton, G., Chen, L., Koontz, S., et al. (2013) · Blood · doi:10.1182/blood-2012-03-420273 · Cited by 97
Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy
de Rham, C., & Villard, J. (2014) · Journal of Immunology Research · doi:10.1155/2014/518135 · Cited by 96
Japanese woman is first recipient of next-generation stem cells
Cyranoski, D. (2014) · Nature · doi:10.1038/nature.2014.15915 · Cited by 89
Banking on iPSC- Is it Doable and is it Worthwhile
Solomon, S., Pitossi, F., & Rao, M. S. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9574-4 · Cited by 86
Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
Kawamata, S., Kanemura, H., Sakai, N., Takahashi, M., & Go, M. J. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010159 · Cited by 80
Human molecular cytogenetics: from cells to nucleotides
Riegel, M. (2014) · Genetics and Molecular Biology · doi:10.1590/s1415-47572014000200006 · Cited by 77
Exome sequencing can detect pathogenic mosaic mutations present at low allele frequencies
Pagnamenta, A. T., Lise, S., Harrison, V., Stewart, H. S., Jayawant, S., Quaghebeur, G., Deng, A. T., Murphy, V., Akha, E. S., Rimmer, A., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.128 · Cited by 76
Reprogramming within hours following nuclear transfer into mouse but not human zygotes
Egli, D., Chen, A. E., Saphier, G., Ichida, J., Fitzgerald, C., Go, K. J., Acevedo, N., Patel, J., Baetscher, M., Kearns, W. G., et al. (2011) · Nature Communications · doi:10.1038/ncomms1503 · Cited by 76
Ruiz, S., Gore, A., Li, Z., Panopoulos, A. D., Montserrat, N., Fung, H.-L., Giorgetti, A., Bilić, J., Batchelder, E. M., Zaehres, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2381 · Cited by 74
Sugiura, M., Kasama, Y., Araki, R., Hoki, Y., Sunayama, M., Uda, M., Nakamura, M., Ando, S., & Abe, M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.006 · Cited by 68
Array comparative genomic hybridization analysis of olfactory neuroblastoma
Guled, M., Myllykangas, S., Frierson, H. F., Mills, S. E., Knuutila, S., & Stelow, E. B. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.57 · Cited by 66
Yasuda, T., Ueno, T., Fukumura, K., Yamato, A., Ando, M., Yamaguchi, H., Soda, M., Kawazu, M., Sai, E., Yamashita, Y., et al. (2013) · Leukemia · doi:10.1038/leu.2013.278 · Cited by 65
High Resolution Array-CGH Characterization of Human Stem Cells Using a Stem Cell Focused Microarray
Elliott, A. M., Elliott, K. A. H., & Kammesheidt, A. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9294-1 · Cited by 62
Wang, B., Miyagoe-Suzuki, Y., Yada, E., Ito, N., Nishiyama, T., Nakamura, M., Ono, Y., Motohashi, N., Segawa, M., Masuda, S., et al. (2011) · PLoS Currents · doi:10.1371/currents.rrn1274 · Cited by 60
An eye to the future: Researchers debate best path for stem cell-derived therapies
Chakradhar, S. (2016) · Nature Medicine · doi:10.1038/nm0216-116 · Cited by 56 · cited 3×
“Even though there was no clear evidence that these mutations could directly lead to adverse effects, the planned transplantation surgery of iPSC-derived RPE sheet was cancelled [9, 10].”
BackgroundWill iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking?
Broxmeyer, H. E. (2010) · Cell stem cell · doi:10.1016/j.stem.2009.12.008 · Cited by 50
Passage Number is a Major Contributor to Genomic Structural Variations in Mouse iPSCs
Liu, P., Kaplan, A., Yuan, B., Hanna, J. H., Lupski, J. R., & Reiner, O. (2014) · Stem Cells · doi:10.1002/stem.1779 · Cited by 46
Genomic copy number and expression patterns in testicular germ cell tumours
McIntyre, A., Summersgill, B., Lu, Y. J., Missiaglia, E., Kitazawa, S., Oosterhuis, J. W., Looijenga, L. H., & Shipley, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604079 · Cited by 41
Few Single Nucleotide Variations in Exomes of Human Cord Blood Induced Pluripotent Stem Cells
Su, R.-J., Yang, Y., Neises, A., Payne, K. J., Wang, J., Viswanathan, K., Wakeland, E. K., Fang, X., & Zhang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059908 · Cited by 39
Making it personal: The prospects for autologous pluripotent stem cell-derived therapies
Blair, N. F., & Barker, R. A. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0057 · Cited by 22 · cited 1×
“These days iPSC-based cell therapies are switching from autologous transplantation to allogeneic transplantation [78].”
Background
Cited by
Ethical and Safety Issues of Stem Cell-Based Therapy
Volarevic, V., Markovic, B. S., Gazdic, M., Volarevic, A., Jovicic, N., Arsenijevic, N., Armstrong, L., Djonov, V., Lako, M., & Stojkovic, M. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.21666 · Cited by 876
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 519
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Glis1 facilitates induction of pluripotency via an epigenome–metabolome–epigenome signalling cascade
Li, L., Chen, K., Wang, T., Wu, Y., Xing, G., Chen, M., Hao, Z., Zhang, C., Zhang, J., Ma, B., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0267-9 · Cited by 315
Human iPSC banking: barriers and opportunities
Huang, C.-Y., Liu, C.-L., Ting, C.-Y., Chiu, Y.-T., Cheng, Y.-C., Nicholson, M. W., & Hsieh, P. C. H. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0578-x · Cited by 216
Metadata
- Authors
- Yoshihara, M., Hayashizaki, Y., & Murakawa, Y.
- Affiliations
- RIKEN (JP)
- Corresponding author
- Murakawa, Yasuhiro
- Venue
- Stem Cell Reviews and Reports
- Published
- 2016-09-05
- Volume
- 13
- Issue
- 1
- Pages
- 7-16
- ISSN
- 1550-8943 (ISSN-L)
- 1558-6804
- PMC
- PMC5346115
- OpenAlex
- W2510668402
- Cited by
- 283
- References
- 119
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 26 · 2023: 19 · 2022: 28 · 2021: 47 · 2020: 34 · 2019: 32 · 2018: 27 · 2017: 28 · 2016: 3
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Stem Cell Reviews and Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science, and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- induced pluripotent stem cells, genomic instability, genetic variation, somatic mutations, iPSC safety, iPSC-based therapy, clinical translation
- MeSH terms
- Cell Differentiation, Humans, Models, Genetic, Risk Factors, Transcription Factors, Genetic Variation, Stem Cell Transplantation, Genomic Instability, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.